VIVE - Viveve Medical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.5M
Enterprise Value 326.15M
Trailing P/E N/A
Forward P/E 1-0.21
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)0.26
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.96
Enterprise Value/EBITDA 6-0.68

Trading Information

Stock Price History

Beta (3Y Monthly) -0.01
52-Week Change 3-97.24%
S&P500 52-Week Change 32.56%
52 Week High 33.7100
52 Week Low 30.0750
50-Day Moving Average 30.1191
200-Day Moving Average 30.4624

Share Statistics

Avg Vol (3 month) 35.03M
Avg Vol (10 day) 34.06M
Shares Outstanding 546.61M
Float 34.22M
% Held by Insiders 12.88%
% Held by Institutions 168.49%
Shares Short (Aug 15, 2019) 46.1M
Short Ratio (Aug 15, 2019) 41.1
Short % of Float (Aug 15, 2019) 415.65%
Short % of Shares Outstanding (Aug 15, 2019) 413.08%
Shares Short (prior month Jul 15, 2019) 44.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-297.12%

Management Effectiveness

Return on Assets (ttm)-66.72%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)13.36M
Revenue Per Share (ttm)0.33
Quarterly Revenue Growth (yoy)-81.00%
Gross Profit (ttm)7.32M
EBITDA -38.69M
Net Income Avi to Common (ttm)-45.55M
Diluted EPS (ttm)-1.1390
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.51M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)31.79M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.98
Book Value Per Share (mrq)-0.29

Cash Flow Statement

Operating Cash Flow (ttm)-39.11M
Levered Free Cash Flow (ttm)-26.18M